1. Home
  2. AROW vs AURA Comparison

AROW vs AURA Comparison

Compare AROW & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • AURA
  • Stock Information
  • Founded
  • AROW 1851
  • AURA 2007
  • Country
  • AROW United States
  • AURA United States
  • Employees
  • AROW N/A
  • AURA N/A
  • Industry
  • AROW Major Banks
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROW Finance
  • AURA Health Care
  • Exchange
  • AROW Nasdaq
  • AURA Nasdaq
  • Market Cap
  • AROW 432.9M
  • AURA 396.8M
  • IPO Year
  • AROW N/A
  • AURA 2021
  • Fundamental
  • Price
  • AROW $28.02
  • AURA $6.56
  • Analyst Decision
  • AROW Hold
  • AURA Strong Buy
  • Analyst Count
  • AROW 1
  • AURA 6
  • Target Price
  • AROW $28.00
  • AURA $22.33
  • AVG Volume (30 Days)
  • AROW 48.8K
  • AURA 239.4K
  • Earning Date
  • AROW 07-24-2025
  • AURA 08-07-2025
  • Dividend Yield
  • AROW 4.05%
  • AURA N/A
  • EPS Growth
  • AROW N/A
  • AURA N/A
  • EPS
  • AROW 1.70
  • AURA N/A
  • Revenue
  • AROW $135,107,000.00
  • AURA N/A
  • Revenue This Year
  • AROW $23.54
  • AURA N/A
  • Revenue Next Year
  • AROW $7.07
  • AURA N/A
  • P/E Ratio
  • AROW $16.49
  • AURA N/A
  • Revenue Growth
  • AROW 3.10
  • AURA N/A
  • 52 Week Low
  • AROW $22.72
  • AURA $4.35
  • 52 Week High
  • AROW $34.63
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • AROW 68.52
  • AURA 57.25
  • Support Level
  • AROW $26.22
  • AURA $6.06
  • Resistance Level
  • AROW $27.70
  • AURA $6.68
  • Average True Range (ATR)
  • AROW 0.70
  • AURA 0.34
  • MACD
  • AROW 0.25
  • AURA -0.01
  • Stochastic Oscillator
  • AROW 95.30
  • AURA 80.00

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: